Aramis Biosciences
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
266 Main St Ste 11 Bldg 2, Medfield, Mas...Phone Number
+39 3494154010Website
www.aramisbio.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Aramis Biosciences
Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company focused on developing disease-modifying therapies for ocular surface diseases, particularly Dry Eye Disease. With approximately 17.8 million diagnosed patients in the U.S., the company aims to address the low treatment rates, as fewer than 1 million currently use FDA-approved products. Their ongoing clinical trials, including the Phase II trial for A197, highlight their commitment to improving treatment options in this area. The intended clients are individuals suffering from ocular surface diseases, specifically those affected by Dry Eye Disease.Explore more
Aramis Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aramis Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Aramis Biosciences launches new products
Aramis Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Aramis Biosciences has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Aramis Biosciences
Funding: Get notified immidiatlly once Aramis Biosciences has new funding data
Check out if Aramis Biosciences is spiking on competitors!
Click to see if Aramis Biosciences had a recent Job posting/layoffs
Earning: See what the market has to say on Aramis Biosciences recently announced quarterly report
Recommended Actions
Find VP level buyers at Aramis Biosciences
Find more new buyers
Compare Similar Companies to Aramis Biosciences
Compare insights from companies similar to Aramis Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aramis Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aramis Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aramis Biosciences.
Aramis Biosciences Tech Stack
A closer look at the technologies used by Aramis Biosciences
See more technologies
Aramis Biosciences News & Media
Aramis Biosciences Announces FDA Clearance of IND Application for A197, a Novel Immunomodulatory Agent for the Treatment of Dry Eye Disease
Aramis Biosciences plans to initiate a Phase II clinical trial in Q1 2022 Aramis Biosciences plans to initiate a Phase II clinical trial in Q1 2022
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aramis Biosciences
Sign Up For FreeTo access detailed company insights
Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company focused on developing disease-modifying therapies for ocular surface diseases, particularly Dry Eye Disease. With approximately 17.8 million diagnosed patients in the U.S., the company aims to address the low treatment rates, as fewer than 1 million currently use... Read More
